ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.

Saved in:
Bibliographic Details
Title: ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.
Authors: Liu Y; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Chen J; Department of Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. HMU_chenjingyu@hotmail.com., Ma L; Radio-chemotherapy Department, The First Hospital of Qiqihar, Qiqihar, China., Zhao S; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Hui X; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Xiong W; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Cheng S; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China. shaoqiangcheng2023@163.com., Zhang Y; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China. zhangyue010@hotmail.com.
Source: Cell biology and toxicology [Cell Biol Toxicol] 2025 Jul 16; Vol. 41 (1), pp. 117. Date of Electronic Publication: 2025 Jul 16.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 8506639 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6822 (Electronic) Linking ISSN: 07422091 NLM ISO Abbreviation: Cell Biol Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-6822
DOI:10.1007/s10565-025-10068-w